• 1
    Baumgartner W, Frese K, Elmadfa I. Neuroaxonal dystrophy associated with vitamin E deficiency in two Haflinger horses. J Comp Pathol 1990;103:114119.
  • 2
    Beech J, Haskins M. Genetic studies of neuraxonal dystrophy in the Morgan. Am J Vet Res 1987;48:109113.
  • 3
    Aleman M, Finno CF, Higgins RJ, et al. Evaluation of epidemiological, clinical and pathologic features of neuroaxonal dystrophy in Quarter horses. J Am Vet Med Assoc 2011;239:623633.
  • 4
    Adams AP, Collatos C, Fuentealba C, Illanes O, Blanchard R. Neuroaxonal dystrophy in a two-year-old quarter horse filly. Can Vet J 1996;37:4344.
  • 5
    Beech J. Neuroaxonal dystrophy of the accessory cuneate nucleus in horses. Vet Pathol 1984;21:384393.
  • 6
    Mayhew IG, Brown CM, Stowe HD, et al. Equine degenerative myeloencephalopathy: A vitamin E deficiency that may be familial. J Vet Intern Med 1987;1:4550.
  • 7
    Blythe LL, Craig AM. Equine degenerative myelencephalopathy: Part I. Clinical signs and pathogenesis. Comp Cont Educ Pract Vet 1992;14:12151221.
  • 8
    Gandini G, Fatzer R, Mariscoli M, et al. Equine degenerative myeloencephalopathy in five Quarter horses: Clinical and neuropathological findings. Equine Vet J 2004;36:8385.
  • 9
    Dill SG, Correa MT, Erb HN, et al. Factors associated with the development of equine degenerative myeloencephalopathy. Am J Vet Res 1990;51:13001305.
  • 10
    Finno CJ, Higgins RJ, Aleman M, et al. Equine degenerative myeloencephalopathy in Lusitano horses. J Vet Intern Med 2011;25:14391446.
  • 11
    Ouahchi K, Arita M, Kayden H, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995;9:141145.
  • 12
    Gotoda T, Arita M, Arai H, et al. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med 1995;333:13131318.
  • 13
    Yokota T, Uchihara T, Kumagai J, et al. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 2000;68:521525.
  • 14
    Strachan T, Read AP. Instability of the human genome: Mutation and DNA repair. In: Strachan T, Read AP, eds. Human Molecular Genetics, 2nd ed. New York: Wiley-Liss; 1999:315349.
  • 15
    Blythe LL, Hultgren BD, Craig AM, et al. Clinical, viral, and genetic evaluation of equine degenerative myeloencephalopathy in a family of Appaloosas. J Am Vet Med Assoc 1991;198:10051013.
  • 16
    Lynch M, Walsh B. Genetics and Analysis of Quantitative Traits. Sunderland, MA: Sinauer Associates, Inc.; 1998.
  • 17
    Elston RC, Namboodiri KK, Glueck CJ, et al. Study of the genetic transmission of hypercholesterolemia and hypertriglyceridemia in a 195 member kindred. Ann Hum Genet 1975;39:6787.
  • 18
    Janss L. iBay Reference Manual, Version 1.33. 2007. []
  • 19
    Smith BJ: boa: Bayesian Output Analysis Program (BOA) for MCMC. R package version 1.6.6 2007.
  • 20
    Plummer M, Best N, Cowles K, Vines K: coda: Output analysis and diagnostics for MCMC. R package version 11-2 2007.
  • 21
    Team RDC: R: A language and environment for statistical computing. Vienna, Austria; 2005.
  • 22
    Geweke J. Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments. In: Bernardo JM, Berger JO, Dawid AP, et al, eds. Bayesian Statistics 4. Oxford: Oxford University Press; 1992:169193
  • 23
    Hyndman R: hdrcde: Highest density regions and conditional density estimation. R package version 2.06 2007.
  • 24
    Kang HM, Sul JH, Service SK, et al. Variance component model to account for sample structure in genome-wide association studies. Nat Genet 2010;42:348354.
  • 25
    Sorensen D, Gianola D. Likelihood, Bayesian and MCMC Methods in Quantitative Genetics. New York: Springer; 2002.
  • 26
    Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Statistical Science 1994;7:457472.
  • 27
    Young AE, Bower LP, Affolter VK, et al. Evaluation of FOXC2 as a candidate gene for chronic progressive lymphedema in draft horses. Vet J 2007;174:397399.
  • 28
    Millis MP. Medium-throughput SNP genotyping using mass spectrometry: multiplex SNP genotyping using the iPLEX(R) gold assay. Methods Mol Biol 2011;700:6176.
  • 29
    Monroe EB, Jurchen JC, Lee J, Rubakhin SS, Sweedler JV. Vitamin E imaging and localization in the neuronal membrane. J Am Chem Soc 2005;127:1215212153.
  • 30
    Nishimura S, Watanabe T, Mizoshita K, et al. Genome-wide association study identified three major QTL for carcass weight including the PLAG1-CHCHD7 QTN for stature in Japanese Black cattle. BMC Genet 2012;13:40.
  • 31
    Bertram L, Tanzi RE. The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 2012;107:79100.
  • 32
    Gourrard PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: An up-to-date review. Immunol Rev 2012;248:87103.
  • 33
    Kummar KR, Djarmati-Westenberger A, Grunewald A. Genetics of Parkinson's disease. Semin Neurol 2011;31:433440.
  • 34
    Siso S, Ferrer I, Pumarola M. Abnormal synaptic protein expression in two Arabian horses with equine degenerative myeloencephalopathy. Vet J 2003;166:238243.
  • 35
    Doria-Lamba L, De Grandis E, Cristiani E, et al. Efficacious vitamin E treatment in a child with ataxia with isolated vitamin E deficiency. Eur J Pediatr 2006;165:494495.
  • 36
    Miller MM, Collatos C. Equine degenerative myeloencephalopathy. Vet Clin North Am Equine Pract 1997;13:4352.
  • 37
    Beech J. Equine degenerative myeloencephalopathy. Vet Clin North Am Equine Pract 1987;3:379383.
  • 38
    Dill SG, Kallfelz FA, deLahunta A, Waldron CH. Serum vitamin E and blood glutathione peroxidase values of horses with degenerative myeloencephalopathy. Am J Vet Res 1989;50:166168.
  • 39
    Zingg JM, Azzi A, Meydani M. Genetic polymorphisms as determinants for disease preventive effects of vitamin E. Nutr Rev 2008;66:406414.